학술논문
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer
Document Type
Article
Author
Source
In: Cancers . (Cancers, September 2022, 14(17))
Subject
Language
English
ISSN
20726694